Method for producing long-chain glycosylated genistein
US-11203743-B2 · Dec 21, 2021 · US
US10876099B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10876099-B2 |
| Application number | US-201815991322-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 29, 2018 |
| Priority date | Jan 15, 2018 |
| Publication date | Dec 29, 2020 |
| Grant date | Dec 29, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to preparation and application of a cyclodextrin glucosyltransferase mutant, belonging to the fields of gene engineering and enzyme engineering. By mutating amino acids of cyclodextrin glucosyltransferase, the enzyme activity of the obtained mutant can reach 2.5 times that of wild enzyme. In addition, the cyclodextrin glucosyltransferase mutant obtained in the present invention is simple in purification and suitable for industrial production.
Opening claim text (preview).
What is claimed is: 1. A cyclodextrin glucosyltransferase mutant, wherein the cyclodextrin glucosyltransferase mutant has the amino acid sequence SEQ ID NO:1 except for one or more mutations selected from the group consisting of K124E, G450S, I465F, I641T, K647E, I631T, double mutant I641T and K647E, and double mutant I641T and 1631T. 2. A method of constructing a recombinant bacterium expressing the mutant of claim 1 , comprising the following steps: designing mutagenic primers of site-directed mutagenesis, performing site-directed mutagenesis by using a vector comprising a gene encoding a parent cyclodextrin glucosyltransferase of SEQ ID NO:1 as a template to generate a gene encoding the mutant of claim 1 ; constructing a plasmid vector containing the gene encoding the mutant of claim 1 ; transforming the vector into a host cell; selecting a positive clone, culturing the positive clone, and centrifuging the culture to generate a supernatant, wherein the supernatant is a crude enzyme solution of the cyclodextrin glucosyltransferase mutant of claim 1 . 3. The method of claim 2 , wherein the vector is a pUC, pET, or pGEX vector. 4. The method of claim 2 , wherein the host cell is a bacterial or fungal cell.
Cyclomaltodextrin glucanotransferase (2.4.1.19) · CPC title
having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin {(C12P19/605)} · CPC title
Cyclomaltodextrin glucanotransferase (2.4.1.19) · CPC title
Vectors or expression systems specially adapted for E. coli · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.